Cellectar Biosciences, Inc. — Director's Dealing 2020

Feb 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-02-03

Reporting Person: Elefant Dov (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-03	Common stock	A	10000	$2.71	Acquired	10000	Direct

Footnotes

F1: Common stock grant that vests in equal annual increments on February 3, 2021, February 3, 2022, and February 3, 2023.